These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12422088)

  • 21. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck.
    Gires O; Mack B; Rauch J; Matthias C
    Biochem Biophys Res Commun; 2006 Apr; 343(1):252-9. PubMed ID: 16540085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
    Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
    Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
    Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
    Clin Cancer Res; 2004 Dec; 10(24):8451-9. PubMed ID: 15625067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of squamous cell carcinoma of the head and neck.
    Wrangle JM; Khuri FR
    Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
    Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
    Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma.
    Shores CG; Yin X; Funkhouser W; Yarbrough W
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):937-42. PubMed ID: 15313863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma.
    Ayude D; Gacio G; Páez de la Cadena M; Pallas E; Martínez-Zorzano VS; de Carlos A; Rodríguez-Berrocal FJ
    Oncol Rep; 2003; 10(5):1345-50. PubMed ID: 12883705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma.
    Wu M; Kafanas A; Gan L; Kohtz DS; Zhang L; Genden E; Burstein DE
    Diagn Cytopathol; 2008 Nov; 36(11):797-800. PubMed ID: 18831009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.
    Lothaire P; de Azambuja E; Dequanter D; Lalami Y; Sotiriou C; Andry G; Castro G; Awada A
    Head Neck; 2006 Mar; 28(3):256-69. PubMed ID: 16284973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.